STUDIES WITH ETHYL CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE).
D000924:Anticholesteremic Agents; D002087:Butyrates; D002245:Carbon Dioxide; D002784:Cholesterol / Q000097:blood*; D002994:Clofibrate; D005989:Glycerides; D006529:Hepatomegaly; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood*; D008099:Liver / Q000502:physiology*; D008798:Mevalonic Acid; D009929:Organ Size; D010477:Perfusion; D010600:Pharmacology; D010743:Phospholipids; D051381:Rats; D012106:Research; D014116:Toxicology
D000924:Anticholesteremic Agents; D002087:Butyrates; D005989:Glycerides; D008055:Lipids; D010743:Phospholipids; D002245:Carbon Dioxide; D002784:Cholesterol; D002994:Clofibrate; D008798:Mevalonic Acid
ANTICHOLESTEREMIC AGENTS; BLOOD CHOLESTEROL; BLOOD LIPIDS; BUTYRATES; CARBON DIOXIDE; CHOLESTEROL; EXPERIMENTAL LAB STUDY; GLYCERIDES; HEPATOMEGALY; LIPID METABOLISM; LIVER FUNCTION; MEVALONIC ACID; ORGAN WEIGHT; PERFUSION; PHARMACOLOGY; PHOSPHOLIPIDS; RATS; TOXICOLOGIC REPORT